Self Regional Healthcare, previously Self Memorial Hospital, is a 358-bed short-term acute care hospital founded on November 1, 1951 in Greenwood, South Carolina. Currently there are over 200 practicing physicians employed by Self Regional Healthcare.

There are 358 beds in Self Regional Healthcare.

During the past decade, Self Regional Healthcare conducted 60 clinical trials. In the 10-year time frame, 60 clinical trials started and 42 clinical trials were completed, i.e. on average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 24 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Self Regional Healthcare" #1 sponsor was "National Cancer Institute (NCI)" with 42 trials, followed by "NRG Oncology" with 18 trials sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "SWOG Cancer Research Network" with 10 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Self Regional Healthcare" #1 collaborator was "National Cancer Institute (NCI)" with 55 trials as a collaborator, "NRG Oncology" with 11 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "Canadian Cancer Trials Group" with 3 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Self Regional Healthcare" are "Recurrent Breast Carcinoma" (6 trials), "Prostate Adenocarcinoma" (5 trials), "Breast Cancer" (4 trials), "Estrogen Receptor Negative" (4 trials) and "Invasive Breast Carcinoma" (4 trials). Many other conditions were trialed in "Self Regional Healthcare" in a lesser frequency.

Most popular intervention types in "Self Regional Healthcare" are "Drug" (79 trials), "Other" (66 trials), "Biological" (32 trials), "Radiation" (28 trials) and "Procedure" (21 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (35 trials), "Quality-of-Life Assessment" (24 trials), "Paclitaxel" (16 trials), "Questionnaire Administration" (14 trials) and "Bevacizumab" (13 trials). Other intervention names were less common.

The vast majority of trials in "Self Regional Healthcare" are 75 trials for "All" genders, 18 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Self Regional Healthcare". undefined are not yet recruiting, 23 are recruiting, 49 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Self Regional Healthcare, 2 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Self Regional Healthcare, 2 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 70 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Self Regional Healthcare has several departments that took part in Clinical trials: "Self Regional Cancer Center at Self Regional Medical Center" - 13 trials